Site na Cocer Peptides 
ụbọchị 24 gara aga.
Usoro metabolic na endocrine na-achịkwa metabolism nke ihe mmadụ, nguzozi ike, na uto na mmepe site na netwọkụ hormonal ọkaibe. Mmebi nke homeostasis a nwere ike ibute nnukwu nsogbu ahụike dịka metabolism, oke ibu, na nsogbu uto. Ihe ndị metụtara ndụ gụnyere nri na-adịghị mma (dịka ọmụmaatụ, nri dị elu na nri edoziri, carbohydrates a nụchara anụcha, na ihe mgbakwunye), omume ịnọkarị otu ebe, ụra ezughi oke, na nchekasị bụ ihe na-akpalite arụrụ ọrụ endocrine. Ihe ndị a abụghị naanị na-enye aka na oke ibu kama ọ na-agbanwekwa mgbaàmà nke metabolic ma na-ebute mbufụt nke sistemu site na ụdị oxygen na-emeghachi omume (ROS) nke sitere na ihe na-ekpughe ihe, na-emebi ahụike metabolic na endocrine. Dịka ọmụmaatụ, eriri afọ microbiota dysbiosis na-akpata nri na ọrịa hormonal-gụnyere nguzogide insulin na mmebi nke homonụ ndị ọzọ na-etinye aka na metabolism na omume inye nri-gụnyere usoro ndị a na-emebi emebi.
N'ime ihe ndabere a, ntinye aka kpọmkwem na nzuzo nke homonụ na usoro metabolic ihe onwunwe dị oke mkpa maka ịnọgide na-enwe ahụike n'ofe ụzọ usoro iwu, dị ka njikwa metabolism, njikwa ibu, iwu homonụ uto, na nkwalite metabolism ume. Pharmaceuticals sitere na peptide, nke ejiri ihe omume dị elu mara ya na ebumnuche ebumnuche siri ike, na-egosipụta uru pụrụ iche n'ụzọ ndị a isi, na-enye ihe ngwọta ọhụrụ maka mgbochi na ọgwụgwọ ọrịa ndị metụtara ya.
Metabolic Health na Endocrine Arụ
Usoro endocrine nwere netwọk dị mgbagwoju anya nke glands na-emepụta ma na-ahapụ homonụ metụtara mmepụta ume, itinye n'ọrụ, nchekwa na omume nri. Ụzọ mgbaàmà nke ọma dị mkpa maka ịhazi metabolism. Ịnọgide na-ahụ maka ahụike metabolic na ọrụ endocrine dị oke egwu, yana mpaghara ngwa ngwa nke ngwaahịa peptide bụ ndị a:
1. Njikwa Metabolism: Iweghachi Glycemic Homeostasis na ichebe megide nsogbu.
N'ime njikwa zuru oke nke ụdị metabolism nke 2, ọgwụ ndị sitere na peptide na-eje ozi dị ka ngwaọrụ dị mkpa maka njikwa glycemic site na ịkwalite mmepụta insulin na itinye n'ọrụ.
Na-akwalite mmepụta insulin
Ụfọdụ peptides (dịka ọmụmaatụ, GLP-1 agonists agonists semaglutide, mazdutide) na-akwalite nnabata glucose nke mkpụrụ ndụ β-pancreatic, na-akwalite mmepụta insulin na-achọsi ike ma na-egbochi mwepụta glucagon na ibelata mmepụta glucose imeju. Nke a na-eme ka ọkwa glucose ọbara dịkwuo mma nke ukwuu na nke postprandial.
Njikwa homonụ nke metabolism: nhazi nke glucose plasma (2023). Site na ScienceDirect.
Na-echekwa ọrụ β-cell pancreatic
Site na igbu oge apoptosis β-cell na ịkwalite mmụba ha, ọgwụ ndị sitere na peptide na-ebelata ọganihu nke metabolism. N'ime ụfọdụ ndị ọrịa, nke a na-eme ka usoro glucose endogenous dịkwuo elu ma belata ịdabere na insulin exogenous.
Na-egbochi nsogbu
Njikwa glycemic kwụsiri ike ma kwụsie ike na-ebelata ohere nke nsogbu microvascular dị ka nephropathy na-arịa ọrịa shuga na retinopathy. Ọ na-emekwa ka ọrụ endothelial vaskụla dịkwuo mma, na-ebelata ihe omume nke obi, ma na-eme ka ndụ dị ogologo oge dịkwuo mma.
2. Njikwa ibu: Ụkpụrụ Multidimensional maka njikarịcha ihe mejupụtara ahụ
Maka ndị buru oke ibu na ndị buru oke ibu, ọgwụ ndị dabere na peptide na-ewepụta nguzozi ọhụrụ n'etiti oriri ume na mmefu site na omume etiti na akụkụ abụọ.
Central agụụ ịkwụsị
peptides satiety (dịka ọmụmaatụ, GLP-1 agonists na-anabata ya) na-arụ ọrụ na ebe nri hypothalamic, na-egbochi mgbasa ozi agụụ na-egbu oge mkpofu afọ. Nke a na-ebelata nke ukwuu agụụ na caloric oriri, na-eduga na-adịgide adịgide arọ ọnwụ, karịsịa irè na mbenata abdominal visceral abụba.
Na-akwalite catabolism abụba
Ụfọdụ peptides (dịka, AOD 9604) na-arụ ọrụ lipase n'ime adipocytes, na-eme ka triglyceride hydrolysis na-agba ọsọ ma na-akwalite oxidation fatty acid maka ume. Ha na-egbochikwa njikọ abụba, na-ebelata mkpokọta abụba anụ ahụ. Ejikọtara ya na ntinye ndụ, mmetụta ndị a na-ebuli njikwa ibu.
Na-achịkwa homonụ ndị metụtara ibu
Site na ịkwalite nguzogide leptin na ịkwalite mmepụta homonụ nke uto, ọgwụ ndị sitere na peptide na-abawanye ọnụego metabolic basal, na-akwalite mmefu ume, ma belata ihe ize ndụ nke ọrịa ndị metụtara oke ibu (dịka ọmụmaatụ, ọbara mgbali elu, hyperlipidemia).
3. Iwu Hormone nke uto: Nkwado ndụ maka mmepe na metabolism
Pharmaceuticals sitere na peptide na-arụ ọrụ dị mkpa n'ofe afọ dị iche iche site n'ịhazi kpọmkwem hormone uto (GH) –insulin-like growth factor-1 (IGF-1) axis.
Na-akwalite uto na mmepe ụmụaka
peptides na-ewepụta homonụ na-eto eto (dịka ọmụmaatụ, semorelin) na-akpali kpọmkwem pituitary GH secretion, na-akwalite uto skeletal linear na mmepe akwara na ụmụaka nwere ụkọ homonụ na-eto eto ma na-emeziwanye nkwụghachi uto n'ozuzu ya.
Na-etinye aka na okenye metabolic ịka nká
Maka ndị agadi na ndị agadi nwere GH na-akpata atrophy muscle atrophy na nchịkọta abụba, peptides dị ka tesamorelin na-akwalite pulsatile GH secretion, ịba ụba anụ ahụ, na-ebelata ntinye abụba abdominal, meziwanye profaịlụ lipid, na igbu oge ịka nká.
Ngwa ọnụọgụ mmadụ pụrụ iche
N'ime ndị ọrịa nwere lipodystrophy metụtara HIV, peptides na-achịkwa hormone na-eto eto na-ahọrọ nke ọma na-ebelata mkpokọta abụba visceral na-adịghị mma, na-eweghachi nguzozi nguzozi nke ihe mejupụtara ahụ, ma melite ọrịa metabolic kpatara ọgwụ.
4. Mmelite Metabolism ike: Nkwalite ụzọ site na cellular ruo n'ọkwa usoro.
Pharmaceuticals sitere na peptide na-akwalite nrụpụta ike itinye n'ọrụ ma na-edozi nsogbu metabolic site n'ịhazi ụzọ metabolism ume n'ọtụtụ akụkụ ahụ.
Na-akwalite ọrụ mitochondrial
Mitochondria-ezubere iche peptides (eg, SS-31) na-echebe mitochondrial akpụkpọ ahụ iguzosi ike n'ezi ihe, na-akwalite adenosine triphosphate (ATP) njikọ, na welie cellular arụmọrụ mmepụta ike. Nke a bara uru karịsịa n'ime akụkụ ahụ ndị nwere ike dị elu dị ka obi na akwara ọkpụkpụ, na-eme ka ike nweta ume na ibelata ike ọgwụgwụ.
Na-achịkwa ọrụ nke enzyme metabolic dị mkpa
Ụfọdụ peptides na-arụ ọrụ ụzọ mmetụta ike dị ka AMPK, na-akwalite nkwupụta nke onye na-ebugharị glucose 4 (GLUT4), na-eme ka nnabata glucose dị na akwara na anụ ahụ adipose, na igbochi gluconeogenesis imeju-si otú ahụ na-eme ka mmetụta insulin dịkwuo elu.
Mmebi nke lipid metabolism na-abawanye
Multitarget peptides (dịka, retatrutide) na-egbochi ọdịiche adipocyte, na-akwalite β-oxidation fatty acid, ma belata triglyceride na ọkwa lipoprotein dị obere (VLDL). Na ọgwụgwọ ọrịa imeju na-adịghị egbu egbu (NAFLD), ha na-egosi ikike ibelata ntinye abụba intrahepatic, na-enye aka na nkwalite zuru oke nke ọrịa metabolic syndrome.
Mmechi
Usoro metabolic na endocrine na-arụ ọrụ na-enweghị atụ na ahụike mmadụ. Dị ka ụzọ ndị bụ isi, njikwa metabolism, njikwa ibu, nhazi nke homonụ na-eto eto, na nkwalite metabolism ume nwere njikọ chiri anya na ọrụ physiological nkịtị na mgbochi ọrịa. Isi nke usoro metabolic na endocrine na-adabere kpọmkwem na njikwa ihe na ike metabolism site na netwọk hormonal, na ịrị elu nke ọgwụ ndị dabeere na peptide enyela ngwá ọrụ enyemaka ezubere iche maka usoro a. Site na ịnọgide na-enwe homeostasis glycemic na ndị ọrịa nwere ọrịa mamịrị ruo n'ịhazigharị ahụ n'ime ndị buru oke ibu, yana site n'ịkwado uto ụmụaka ruo igbu oge ịka nká nke ndị okenye, ọgwụ ndị sitere na peptide na-egosipụta uru ngwa ogologo ndụ. Uru ha na-agbatị karịa imeziwanye ihe ngosi otu; ha na-eme ka ntinye aka zuru oke na nsogbu ndị dị mgbagwoju anya dị ka nsogbu ọrịa shuga, ihe egwu obi, na arụ ọrụ akụkụ ahụ site na nhazi ọtụtụ ụzọ.
Edemede na ozi ngwaahịa niile enyere na webụsaịtị a bụ naanị maka mgbasa ozi na ebumnuche mmụta.
Ngwaahịa ndị enyere na webụsaịtị a bụ naanị maka nyocha in vitro. A na-eme nyocha in vitro (Latin: * na iko *, nke pụtara na ihe eji enyo) na mpụga ahụ mmadụ. Ngwaahịa ndị a abụghị ọgwụ, ndị US Food and Drug Administration (FDA) akwadobeghị ya, ha agaghịkwa eji ya gbochie, gwọọ, ma ọ bụ gwọọ ọnọdụ ahụike ọ bụla, ọrịa, ma ọ bụ ọrịa. Iwu amachibidoro nke ọma iwebata ngwaahịa ndị a n'ime ahụ mmadụ ma ọ bụ anụmanụ n'ụdị ọ bụla.
